William Blair analyst Ralph Schackart is out with a research report on Netflix, Inc. (NASDAQ:NFLX) underscoring how the video streaming giant’s original content …
As he previews fourth-quarter results for these two biotech giants, William Blair analyst John Sonnier is setting positive expectations on Gilead Sciences, Inc. (NASDAQ:GILD) …
Canaccord analyst John Newman weighs in on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), as competitor Ironwood Pharmaceuticals (NASDAQ:IRWD) has a PDUFA date of February 9, 2017 for …
Previewing fourth-quarter earnings, Jefferies analyst Brian Fitzgerald is setting confident expectations on the following large-cap internet stocks in his coverage: Facebook Inc (NASDAQ:FB), Amazon.com, …
U.S.
As REDUCE-IT continues to track to expected read-outs in early 2018, H.C.
Analysts from Oppenheimer and Baird are speculating on Amazon.com, Inc.
Piper Jaffray analyst Michael Olson previews Apple Inc. (NASDAQ:AAPL) ahead of its first fiscal quarter of 2017 print due January 31st from a …
Late last week, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced the FDA approval of its lead drug Trulance (plecanatide) for the treatment of adults with …
RBC Capital top analyst Mark Mahaney weighed in today with his views on Alphabet Inc (NASDAQ:GOOGL), as the company is scheduled to report its fiscal …
